Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.

Liau LM, Ashkan K, Tran DD, Campian JL, Trusheim JE, Cobbs CS, Heth JA, Salacz M, Taylor S, D'Andre SD, Iwamoto FM, Dropcho EJ, Moshel YA, Walter KA, Pillainayagam CP, Aiken R, Chaudhary R, Goldlust SA, Bota DA, Duic P, Grewal J, Elinzano H, Toms SA, Lillehei KO, Mikkelsen T, Walpert T, Abram SR, Brenner AJ, Brem S, Ewend MG, Khagi S, Portnow J, Kim LJ, Loudon WG, Thompson RC, Avigan DE, Fink KL, Geoffroy FJ, Lindhorst S, Lutzky J, Sloan AE, Schackert G, Krex D, Meisel HJ, Wu J, Davis RP, Duma C, Etame AB, Mathieu D, Kesari S, Piccioni D, Westphal M, Baskin DS, New PZ, Lacroix M, May SA, Pluard TJ, Tse V, Green RM, Villano JL, Pearlman M, Petrecca K, Schulder M, Taylor LP, Maida AE, Prins RM, Cloughesy TF, Mulholland P, Bosch ML.

J Transl Med. 2018 May 29;16(1):142. doi: 10.1186/s12967-018-1507-6.

2.

A Comparative Report on Intracranial Tumor-to-Tumor Metastasis and Collision Tumors.

Syed S, Karambizi DI, Baker A, Groh DM, Toms SA.

World Neurosurg. 2018 Apr 26. pii: S1878-8750(18)30829-5. doi: 10.1016/j.wneu.2018.04.109. [Epub ahead of print]

PMID:
29704691
3.

Tumor-treating fields as a fourth treating modality for glioblastoma: a meta-analysis.

Magouliotis DE, Asprodini EK, Svokos KA, Tasiopoulou VS, Svokos AA, Toms SA.

Acta Neurochir (Wien). 2018 Jun;160(6):1167-1174. doi: 10.1007/s00701-018-3536-6. Epub 2018 Apr 25.

PMID:
29696502
4.

Fighting Fire with Fire: Surgical Options for Patients with Drug-Resistant Epilepsy.

Bayer AD, Blum AS, Asaad WF, Roth J, Toms SA, Deck GM.

R I Med J (2013). 2018 Mar 1;101(2):37-40.

PMID:
29490324
5.

Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma: A Secondary Analysis of a Randomized Clinical Trial.

Taphoorn MJB, Dirven L, Kanner AA, Lavy-Shahaf G, Weinberg U, Taillibert S, Toms SA, Honnorat J, Chen TC, Sroubek J, David C, Idbaih A, Easaw JC, Kim CY, Bruna J, Hottinger AF, Kew Y, Roth P, Desai R, Villano JL, Kirson ED, Ram Z, Stupp R.

JAMA Oncol. 2018 Apr 1;4(4):495-504. doi: 10.1001/jamaoncol.2017.5082.

6.

Macropinocytosis of Bevacizumab by Glioblastoma Cells in the Perivascular Niche Affects their Survival.

Müller-Greven G, Carlin CR, Burgett ME, Ahluwalia MS, Lauko A, Nowacki AS, Herting CJ, Qadan MA, Bredel M, Toms SA, Lathia JD, Hambardzumyan D, Sarkaria JN, Hamerlik P, Gladson CL.

Clin Cancer Res. 2017 Nov 15;23(22):7059-7071. doi: 10.1158/1078-0432.CCR-17-0249. Epub 2017 Sep 14.

PMID:
28912141
7.

Cladophialophora Bantiana : A Rare Intracerebral Fungal Abscess-Case Series and Review of Literature.

Ahmad M, Jacobs D, Wu HH, Wolk DM, Kazmi SAJ, Jaramillo C, Toms SA.

Surg J (N Y). 2017 Mar 30;3(2):e62-e68. doi: 10.1055/s-0037-1598248. eCollection 2017 Apr.

8.

Recent Advances in the Treatment of Gliomas - Comprehensive Brain Tumor Center.

Toms SA, Tapinos N.

R I Med J (2013). 2017 Jun 1;100(6):43-46. Review.

PMID:
28564669
9.

Episode-Based Payment and Direct Employer Purchasing of Healthcare Services: Recent Bundled Payment Innovations and the Geisinger Health System Experience.

Slotkin JR, Ross OA, Newman ED, Comrey JL, Watson V, Lee RV, Brosious MM, Gerrity G, Davis SM, Paul J, Miller EL, Feinberg DT, Toms SA.

Neurosurgery. 2017 Apr 1;80(4S):S50-S58. doi: 10.1093/neuros/nyx004.

PMID:
28375499
10.

Aberrations in the Iron Regulatory Gene Signature Are Associated with Decreased Survival in Diffuse Infiltrating Gliomas.

Weston C, Klobusicky J, Weston J, Connor J, Toms SA, Marko NF.

PLoS One. 2016 Nov 29;11(11):e0166593. doi: 10.1371/journal.pone.0166593. eCollection 2016.

11.

The Acetazolamide Challenge: A Tool for Surgical Decision Making and Predicting Surgical Outcome in Patients with Arachnoid Cysts.

Kershenovich A, Toms SA.

J Neurol Surg A Cent Eur Neurosurg. 2017 Jan;78(1):33-41. doi: 10.1055/s-0036-1584815. Epub 2016 Jul 14.

PMID:
27415592
12.

Treatment for Patients With Newly Diagnosed Glioblastoma--Reply.

Stupp R, Toms SA, Kesari S.

JAMA. 2016 Jun 7;315(21):2348-9. doi: 10.1001/jama.2016.1847. No abstract available.

13.

Technological Advances in the Treatment of Cancer: Combining Modalities to Optimize Outcomes.

Wong ET, Toms SA, Ahluwalia MS.

Clin Adv Hematol Oncol. 2015 Nov;13(11 Suppl 11):1-18.

PMID:
26862770
14.

Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial.

Stupp R, Taillibert S, Kanner AA, Kesari S, Steinberg DM, Toms SA, Taylor LP, Lieberman F, Silvani A, Fink KL, Barnett GH, Zhu JJ, Henson JW, Engelhard HH, Chen TC, Tran DD, Sroubek J, Tran ND, Hottinger AF, Landolfi J, Desai R, Caroli M, Kew Y, Honnorat J, Idbaih A, Kirson ED, Weinberg U, Palti Y, Hegi ME, Ram Z.

JAMA. 2015 Dec 15;314(23):2535-43. doi: 10.1001/jama.2015.16669.

PMID:
26670971
15.

Sustained Local Release of Methylprednisolone From a Thiol-Acrylate Poly(Ethylene Glycol) Hydrogel for Treating Chronic Compressive Radicular Pain.

Slotkin JR, Ness JK, Snyder KM, Skiles AA, Woodard EJ, OʼShea T, Layer RT, Aimetti AA, Toms SA, Langer R, Tapinos N.

Spine (Phila Pa 1976). 2016 Apr;41(8):E441-8. doi: 10.1097/BRS.0000000000001309.

PMID:
26630427
16.

Notch receptor expression in human brain arteriovenous malformations.

Hill-Felberg S, Wu HH, Toms SA, Dehdashti AR.

J Cell Mol Med. 2015 Aug;19(8):1986-93. doi: 10.1111/jcmm.12580. Epub 2015 Apr 3.

17.

Intraoperative radiotherapy to treat newly diagnosed solitary brain metastasis: initial experience and long-term outcomes.

Weil RJ, Mavinkurve GG, Chao ST, Vogelbaum MA, Suh JH, Kolar M, Toms SA.

J Neurosurg. 2015 Apr;122(4):825-32. doi: 10.3171/2014.11.JNS1449. Epub 2015 Jan 23.

PMID:
25614945
18.

The effect of field strength on glioblastoma multiforme response in patients treated with the NovoTTF™-100A system.

Turner SG, Gergel T, Wu H, Lacroix M, Toms SA.

World J Surg Oncol. 2014 May 22;12:162. doi: 10.1186/1477-7819-12-162.

19.

Molecular biology of brain metastasis.

Svokos KA, Salhia B, Toms SA.

Int J Mol Sci. 2014 May 28;15(6):9519-30. doi: 10.3390/ijms15069519. Review.

20.

Maximum safe resection of glioblastoma multiforme.

Lacroix M, Toms SA.

J Clin Oncol. 2014 Mar 10;32(8):727-8. doi: 10.1200/JCO.2013.53.2788. Epub 2014 Feb 10. No abstract available.

PMID:
24516027
21.

High fluorodeoxyglucose ((18)F)PET-uptake lymph nodes in a patient with chordoma: Tumor metastasis or sarcoidosis?

Gharavi MH, Wu HH, Toms SA.

Am J Case Rep. 2013 Sep 17;14:373-5. doi: 10.12659/AJCR.889329. eCollection 2013.

22.

Comparative effectiveness research in neurotrauma.

Timmons SD, Toms SA.

Neurosurg Focus. 2012 Jul;33(1):E3. doi: 10.3171/2012.6.FOCUS1296. Review.

PMID:
22746235
23.

Reengineering acute episodic and chronic care delivery: the Geisinger Health System experience.

Slotkin JR, Casale AS, Steele GD Jr, Toms SA.

Neurosurg Focus. 2012 Jul;33(1):E16. doi: 10.3171/2012.4.FOCUS1293. Review.

PMID:
22746233
24.

The molecular biology of brain metastasis.

Rahmathulla G, Toms SA, Weil RJ.

J Oncol. 2012;2012:723541. doi: 10.1155/2012/723541. Epub 2012 Mar 8.

25.

Use of Hemostatic Matrix for Hemostasis of the Cavernous Sinus during Endoscopic Endonasal Pituitary and Suprasellar Tumor Surgery.

Bedi AD, Toms SA, Dehdashti AR.

Skull Base. 2011 May;21(3):189-92. doi: 10.1055/s-0031-1275632.

26.

Stereotactic radiosurgical treatment of brain metastases to the choroid plexus.

Siomin V, Lin JL, Marko NF, Barnett GH, Toms SA, Chao ST, Angelov L, Vogelbaum MA, Navaratne K, Suh JH, Weil RJ.

Int J Radiat Oncol Biol Phys. 2011 Jul 15;80(4):1134-42. doi: 10.1016/j.ijrobp.2010.03.016.

PMID:
21683888
27.

The molecular pathobiology of metastasis to the brain: a review.

Beasley KD, Toms SA.

Neurosurg Clin N Am. 2011 Jan;22(1):7-14, v. doi: 10.1016/j.nec.2010.08.009. Review.

PMID:
21109144
28.

Stereotactic radiosurgery as single-modality treatment of incidentally identified renal cell carcinoma brain metastases.

Marko NF, Angelov L, Toms SA, Suh JH, Chao ST, Vogelbaum MA, Barnett GH, Weil RJ.

World Neurosurg. 2010 Mar;73(3):186-93; discussion e29. doi: 10.1016/j.surneu.2009.02.011. Epub 2009 Jul 15.

PMID:
20860956
29.

Nanoimaging and neurological surgery.

Grosu ID, Toms MA, Toms SA.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010 Nov-Dec;2(6):601-17. doi: 10.1002/wnan.106. Review.

PMID:
20669333
30.

Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme.

Peereboom DM, Shepard DR, Ahluwalia MS, Brewer CJ, Agarwal N, Stevens GH, Suh JH, Toms SA, Vogelbaum MA, Weil RJ, Elson P, Barnett GH.

J Neurooncol. 2010 May;98(1):93-9. doi: 10.1007/s11060-009-0067-2. Epub 2009 Dec 4.

PMID:
19960228
31.

Intraoperative optical spectroscopy identifies infiltrating glioma margins with high sensitivity.

Toms SA, Lin WC, Weil RJ, Johnson MD, Jansen ED, Mahadevan-Jansen A.

Neurosurgery. 2007 Jul;61(1 Suppl):327-35; discussion 335-6. doi: 10.1227/01.neu.0000279226.68751.21.

PMID:
18813157
32.

Stereotactic radiosurgical treatment of brain metastases in older patients.

Kim SH, Weil RJ, Chao ST, Toms SA, Angelov L, Vogelbaum MA, Suh JH, Barnett GH.

Cancer. 2008 Aug 15;113(4):834-40. doi: 10.1002/cncr.23625.

33.

Clinical problem-solving: island intruder.

Toms SA, Weil RJ, Gupta A, Boulis NM, Prayson R, Lang FF.

Neurosurgery. 2008 Apr;62(4):920-8; discussion 928-9. doi: 10.1227/01.neu.0000318178.95288.2f. No abstract available.

PMID:
18496198
34.

Imaging characteristics of zinc sulfide shell, cadmium telluride core quantum dots.

Daneshvar H, Nelms J, Muhammad O, Jackson H, Tkach J, Davros W, Peterson T, Vogelbaum MA, Bruchez MP, Toms SA.

Nanomedicine (Lond). 2008 Feb;3(1):21-9. doi: 10.2217/17435889.3.1.21.

PMID:
18393664
35.

Genomic expression patterns distinguish long-term from short-term glioblastoma survivors: a preliminary feasibility study.

Marko NF, Toms SA, Barnett GH, Weil R.

Genomics. 2008 May;91(5):395-406. doi: 10.1016/j.ygeno.2008.01.002. Epub 2008 Mar 17.

36.

Stereotactic radiosurgical treatment of parenchymal brain metastases from prostate adenocarcinoma.

Kim SH, Chao ST, Toms SA, Vogelbaum MA, Barnett GH, Suh JH, Weil RJ.

Surg Neurol. 2008 Jun;69(6):641-6; discussion 646. doi: 10.1016/j.surneu.2007.05.035. Epub 2008 Feb 8.

PMID:
18262258
37.

Nanotechnology in proteomics.

Marko NF, Weil RJ, Toms SA.

Expert Rev Proteomics. 2007 Oct;4(5):617-26. Review.

PMID:
17941817
38.

Neurogenesis in the postnatal human epileptic brain.

González-Martínez JA, Bingaman WE, Toms SA, Najm IM.

J Neurosurg. 2007 Sep;107(3):628-35.

PMID:
17886564
39.

Choroid plexus metastasis.

Toms SA, Suh JH, Weil RJ.

Urology. 2007 Aug;70(2):370-1. No abstract available.

PMID:
17826512
40.

New prospects for management and treatment of inoperable and recurrent skull base meningiomas.

Johnson MD, Sade B, Milano MT, Lee JH, Toms SA.

J Neurooncol. 2008 Jan;86(1):109-22. Epub 2007 Jul 12. Review.

PMID:
17624496
41.

Symptomatic pituitary metastases from renal cell carcinoma.

Gopan T, Toms SA, Prayson RA, Suh JH, Hamrahian AH, Weil RJ.

Pituitary. 2007;10(3):251-9.

PMID:
17541748
42.

Quantum dots are phagocytized by macrophages and colocalize with experimental gliomas.

Jackson H, Muhammad O, Daneshvar H, Nelms J, Popescu A, Vogelbaum MA, Bruchez M, Toms SA.

Neurosurgery. 2007 Mar;60(3):524-9; discussion 529-30.

PMID:
17327798
43.

Macrophage-mediated colocalization of quantum dots in experimental glioma.

Muhammad O, Popescu A, Toms SA.

Methods Mol Biol. 2007;374:161-71.

PMID:
17237538
44.

In vivo optical imaging using quantum dots for the management of brain tumors.

Popescu MA, Toms SA.

Expert Rev Mol Diagn. 2006 Nov;6(6):879-90. Review.

PMID:
17140375
45.

RPA classification has prognostic significance for surgically resected single brain metastasis.

Tendulkar RD, Liu SW, Barnett GH, Vogelbaum MA, Toms SA, Jin T, Suh JH.

Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):810-7.

PMID:
17011454
46.

Five-year survivors of brain metastases: a single-institution report of 32 patients.

Chao ST, Barnett GH, Liu SW, Reuther AM, Toms SA, Vogelbaum MA, Videtic GM, Suh JH.

Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):801-9. Epub 2006 Aug 14.

PMID:
16904847
47.

Neuro-oncological applications of optical spectroscopy.

Toms SA, Konrad PE, Lin WC, Weil RJ.

Technol Cancer Res Treat. 2006 Jun;5(3):231-8. Review.

PMID:
16700619
48.

Intraoperative optical spectroscopy identifies infiltrating glioma margins with high sensitivity.

Toms SA, Lin WC, Weil RJ, Johnson MD, Jansen ED, Mahadevan-Jansen A.

Neurosurgery. 2005 Oct;57(4 Suppl):382-91; discussion 382-91.

PMID:
16234690
49.

In vivo optical spectroscopy detects radiation damage in brain tissue.

Lin WC, Mahadevan-Jansen A, Johnson MD, Weil RJ, Toms SA.

Neurosurgery. 2005 Sep;57(3):518-25; discussion 518-25.

PMID:
16145531
50.

Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry.

Schwartz SA, Weil RJ, Thompson RC, Shyr Y, Moore JH, Toms SA, Johnson MD, Caprioli RM.

Cancer Res. 2005 Sep 1;65(17):7674-81.

Supplemental Content

Support Center